Literature DB >> 10799481

Cu2+ and Zn2+ inhibit nitric-oxide synthase through an interaction with the reductase domain.

J M Perry1, Y Zhao, M A Marletta.   

Abstract

Cu(2+) and Zn(2+) inhibit all of the NADPH-dependent reactions catalyzed by neuronal nitric-oxide synthase (nNOS) including ferricytochrome c reduction, NADPH oxidation, and citrulline formation. Cu(2+) and Zn(2+) also inhibit ferricytochrome c reduction by the independent reductase domain. Zn(2+) affects all activities of the full-length nNOS and the reductase domain to the same extent (estimated IC(50) values from 9 to 31 microm), suggesting Zn(2+) occupation of a single site in the reductase domain. Citrulline formation and NADPH oxidation by the full-length nNOS and ferricytochrome c reduction by the reductase domain are affected similarly by Cu(2+), with estimated IC(50) values ranging from 6 to 33 microm. However, Cu(2+) inhibits ferricytochrome c reduction by the full-length nNOS 2 orders of magnitude more potently, with an estimated IC(50) value of 0.12 microm. These data suggest the possibility that Cu(2+) may interact with nNOS at two sites, one composed exclusively of the reductase domain (which is perhaps also involved in Zn(2+)-mediated inhibition), and another that includes components of both domains. Occupation of the second (higher affinity) site could then promote the selective inhibition of ferricytochrome c reduction in full-length nNOS. Neither the inhibition by Cu(2+) nor that by Zn(2+) is dependent on calmodulin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799481     DOI: 10.1074/jbc.275.19.14070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.

Authors:  Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells
Journal:  Physiol Genomics       Date:  2005-08-23       Impact factor: 3.107

2.  Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.

Authors:  Ha T Do; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2019-02-25       Impact factor: 7.446

3.  Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Tanea T Reed; Marzia Perluigi; Carlo De Marco; Raffaella Coccia; Jeffrey N Keller; William R Markesbery; Rukhsana Sultana
Journal:  Brain Res       Date:  2007-03-07       Impact factor: 3.252

4.  Age-related changes in nitric oxide synthase in the lateral geniculate nucleus of rats.

Authors:  Seung-Jun Hwang; Youngbuhm Huh
Journal:  J Mol Histol       Date:  2010-05-17       Impact factor: 2.611

5.  Identification of mouse brain proteins associated with isoform 3 of metallothionein.

Authors:  David W Lahti; John D Hoekman; Abigail M Tokheim; Bruce L Martin; Ian M Armitage
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

6.  Neuronal Nitric Oxide Synthase Negatively Regulates Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration.

Authors:  Brajesh Kumar Singh; Vinod Kumar; Amit Kumar Chauhan; Ashish Dwivedi; Shweta Singh; Ashutosh Kumar; Deepali Singh; Devendra Kumar Patel; Ratan Singh Ray; Swatantra Kumar Jain; Chetna Singh
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

7.  Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.

Authors:  Giovanna Cenini; Rukhsana Sultana; Maurizio Memo; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2008-04-08       Impact factor: 7.376

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.